CDER New May 27, 2016

What's New on the FDA Drugs Site

May 26, 2016

• FDA approves Probuphine, the first buprenorphine implant for treatment of opioid dependence
• FDA Drug Safety Podcast: Interim clinical trial results find increased risk of leg and foot amputations, mostly affecting the toes, with the diabetes medicine canagliflozin (Invokana, Invokamet); FDA to investigate
• Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies (updated)
• Neonatal opioid withdrawal syndrome and medication-assisted treatment with methadone and buprenorphine